Disseminated Toxoplasmosis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient: A Case Report and Review of the Current Literature.
bone marrow transplant
cns toxoplasmosis
double umbilical cord blood transplant
pyrimethamine
sulfadiazine
toxoplasmosis gondii
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
accepted:
15
09
2022
entrez:
19
10
2022
pubmed:
20
10
2022
medline:
20
10
2022
Statut:
epublish
Résumé
Reactivation infections in hematopoietic stem cell transplants are mitigated by prophylactic regimens. Despite high rates of exposure, morbidity and mortality secondary to toxoplasmosis are limited to subsets of patients such as immunocompromised persons. We describe the first case of disseminated toxoplasmosis in a double umbilical cord blood transplant recipient.
Identifiants
pubmed: 36259018
doi: 10.7759/cureus.29185
pmc: PMC9569131
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e29185Informations de copyright
Copyright © 2022, Baluch et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Clin Infect Dis. 2010 Sep 15;51(6):716-7, 749-50
pubmed: 20731564
Bone Marrow Transplant. 2009 Oct;44(8):453-5
pubmed: 19861977
Clin Infect Dis. 2001 Jan;32(1):E1-8
pubmed: 11118397
Bone Marrow Transplant. 2000 May;25(9):969-73
pubmed: 10800065
Bone Marrow Transplant. 2000 Jun;25(12):1257-62
pubmed: 10871730
Transpl Infect Dis. 2012 Oct;14(5):496-501
pubmed: 22548804
Bone Marrow Transplant. 2002 Apr;29(8):691-8
pubmed: 12180115
Mediterr J Hematol Infect Dis. 2016 Jul 01;8(1):e2016035
pubmed: 27413527
Clin Microbiol Infect. 2008 Dec;14(12):1089-101
pubmed: 19018809
Pediatr Blood Cancer. 2007 Feb;48(2):222-6
pubmed: 16333839